Histology and Immunohistochemistry Services

• Research type

  Research Study

• Full title

  Histology and Immunohistochemistry (IHC) Services to the Pharmaceutical and Biotechnology Sectors, in support of biomarker projects, preclinical programmes and clinical trials.

• IRAS ID

  272410

• Contact name

  Andrew Lawrence

• Contact email

  andrew.lawrence@histologix.co.uk

• Sponsor organisation

  Histologix

• Duration of Study in the UK

  5 years, 0 months, 0 days

• Research summary

  Histologix performs a wide range of services including to the pharmaceutical and biotechnology sectors including proof of principle/mechanism studies, antibody/target identification, mutational studies targeting RNA, efficacy studies using over expressing cell lines or xenografts, target distribution studies in normal and diseased tissues, cytokine release assays, IHC/ISH expression, clinical trial patient biopsy screening and therapeutic antibody cross reactivity testing in line with European Medicines Agency.

• REC name

  North West - Haydock Research Ethics Committee

• REC reference

  19/NW/0708

• Date of REC Opinion

  25 Nov 2019

• REC opinion

  Unfavourable Opinion